USPTO serial 79364279
DERMACYTE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- TMO LAW OFFICE 110
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with DERMACYTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian M. Davis
Brian M. Davis VLP Law Group LLP5960 Fairview Rd; Suite 400Charlotte, NC 28210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical and veterinary preparations for the treatment of damaged skin and tissue; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of diseases, autoimmune diseases, allergies, allergic diseases, skin diseases, dermatitis, psoriasis, pruritic conditions, viral infections, coronaviruses, and inflammatory diseases; pharmaceutical, medical and veterinary preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, autoimmune diseases, allergies, allergic diseases, skin diseases, dermatitis, psoriasis, pruritic conditions, viral infections, coronaviruses and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, autoimmune diseases, allergies, allergic diseases, skin diseases, dermatitis, psoriasis, pruritic conditions, viral infections, coronaviruses and inflammatory diseases, for animals; pharmaceutical, medical and veterinary preparations for the treatment of dermatitis; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drugs for medical purposes, namely, pharmaceutical preparations for treating allergies; biological preparations for medical use for the treatment of cancer; biological reagents for medical use; biological tissue cultures for medical use; biochemical preparations for medical use for the treatment of autoimmune diseases; anti-virals; diagnostic preparations for medical and veterinary purposes; clinical veterinary diagnostic reagents; immunoassay reagents for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 1, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 16, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 16, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 24, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 16, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 16, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 17, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 31, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 31, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 1, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 1, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 1, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 13, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |